Ilika moves closer to commercialising its large‑format solid‑state batteries

Ilika Plc

The recent progress at Ilika points to a company actively positioning itself for commercial relevance in the electric vehicle supply chain. While many solid‑state battery concepts remain stuck in the lab, Ilika’s Goliath programme is beginning to show the kind of practical advances that matter to OEMs and long‑term investors alike.

The Goliath programme focuses on developing large‑format pouch cells using solid‑state technology built around a solid ceramic electrolyte and a high‑energy silicon anode. This combination allows for improved thermal stability, greater energy density, and potentially faster charging.

In April 2025, Ilika confirmed that cells manufactured using production‑grade equipment at the UK Battery Industrialisation Centre achieved higher yields and faster charge performance than earlier prototypes. It means the company is now working with equipment and processes that mirror commercial settings, rather than relying on lab tools. As part of its roadmap, Ilika is building a 1.5 MWh pre‑commercial production line, which will supply evaluation cells to automotive partners and Tier 1 suppliers.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search